Scientific Advisory Board

Max Planck Institutes are assessed by an independent scientific advisory board on a regular basis to ensure consistent, high-quality research. The board members are selected by the president of the Max Planck Society in the light of suggestions from the institute, for a maximum term of six years.

The scientific advisory board of the Max Planck Institute for Medical Research currently includes ten members.

Prof. Dr. Rudolf Glockshuber

ETH Zürich, Department of Biology, Institute for Molecular Biology and Biophysics

Prof. Dr. Itaru Hamachi

Kyoto University, Institute for Integrated Cell-Material Sciences

Prof. Dr. Ehud Isacoff

University of California, Department of Molecular and Cell Biology

Prof. Dr. Clemens Kaminski

University of Cambridge, Department of Chemical Engineering and Biotechnology

Prof. Dr. Josef A. Käs

University of Leipzig, Soft Matter Physics Division Biophysics

Prof. Dr. Alanna Schepartz

Yale University, Department of Chemistry

Prof. Dr. Ben Schuler

Universität Zürich, Department of Biochemistry

Prof. Dr. Janet Smith

University of Michigan, Life Sciences Institute

Prof. Dr. Lydia Sorokin

Westfälische Wilhelms-Universität Münster, Institute for Physiological Chemistry and Pathobiochemistry

Prof. Dr. Shimon Weiss

University of California, Department of Chemistry and Biochemistry

 
loading content
Go to Editor View